A Study to Evaluate the Safety and Efficacy of Max-40279 and Toripalimab in Patients With Advanced Solid Tumors

Status:
Recruiting

Trial end date:
2023-08-31

Target enrollment:

Participant gender:

This include two parts, part 1 is a dose escalation study and part 2 is a dose expansion study.

Phase 1

Maxinovel Pty., Ltd.